Governor Cuomo Recognizes Clarifi COVID-19 Test Kit as Most Sensitive Saliva Test

Announcement Archives - Quadrant Biosciences

Governor Cuomo Recognizes Clarifi COVID-19 Test Kit as Most Sensitive Saliva Test

This past December, the United States Food and Drug Administration (FDA) ranked the Clarifi COVID-19 Test Kit as the most sensitive COVID-19 saliva test currently available on the market.  In a statement released by the office of Governor Andrew Cuomo, the Governor congratulated Quadrant Biosciences and SUNY Upstate Medical for our work developing the Clarifi

Read More...

Quadrant Biosciences Receives “Project of the Year” Award

Quadrant Biosciences and SUNY Upstate Medical University have been chosen as recipients of MedTech’s 2020 Project of the Year award for the development of the Clarifi COVID-19 saliva test. The award recognizes an initiative that has had a “singular and demonstrable positive impact on public health.” The Clarifi COVID-19 saliva test was co-developed by Quadrant

Read More...

New York Gov Cuomo Announces COVID-19 Testing Program

Over the past six months, Quadrant Biosciences has been working in collaboration with New York State to develop and implement several COVID-19 detection projects. These include a program to detect the SARS-CoV-2 RNA virus in wastewater, and a pooled testing program for New York colleges.  In a recent press release, Governor Cuomo announced these new

Read More...

Quadrant Biosciences Developing Saliva Swab for COVID-19

We’re excited to share that our company has been working on a new, rapid diagnostic test for COVID-19. Once again, we’ve partnered with researchers at SUNY Upstate Medical University to develop this saliva-based RNA assay.  As you know, we have developed the world’s first epigenetic saliva test for autism called Clarifi™ ASD. When the COVID-19

Read More...

Quadrant Biosciences Offers Common Shares of the Company

We’re excited to share a new opportunity for investors looking to help improve the lives of  families across the country.  Quadrant Biosciences is now offering common shares to the general public through the equity crowdfunding platform, Wefunder.  This campaign is the first time Quadrant is offering shares to the public at large, however we’ve previously

Read More...

COVID-19 Resources for Families with Autism

With the continued spread of COVID-19, families everywhere are taking precautions to stay healthy. But for families who have a child with autism, some of those precautions, like social distancing for example, may be especially stressful.  So we thought it would be helpful to compile some tips and links to resources from various autism and

Read More...

Quadrant Biosciences on Capitol Hill

An update from the CEO, Rich Uhlig. I hope everyone is staying safe in these tumultuous times. I wanted to update you on my recent visit to Washington D.C. to engage with key members of Congress and the Executive Branch about our autism saliva test, Clarifi ASD. My colleagues from Quadrant and I had the

Read More...

Autism Awareness Day with the Syracuse Mets

This past weekend, baseball fans all around Syracuse, NY were able to watch their local Mets play live, without the sensory overload. We were happy to be able to bring Autism Awareness Day back to our community, with the help of our partners at Upstate Medical University. With autistic baseball fans in mind, the game

Read More...

Quadrant Biosciences Rebrands

Have you visited our website recently? If so, you’ve seen some significant changes in the look of our site.  Since our company’s inception over 5 years ago, our mission has been to find biological solutions for important neurological health issues.  At first, this stemmed from our Founder and CEO Rich Uhlig’s desire to have better

Read More...